ResearcherAmsterdam University Medical CentersActive in the last 2 years
Lenka N.C. Boyd
Matched on ORCID iD 0000-0002-7441-6696; OpenAlex author ID A5033823601. Sources: OpenAlex.
Their work
- Papers
- 10 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 26
2020: 1 paper · 2021: 1 paper · 2022: 1 paper · 2023: 4 papers · 2024: 3 papers
Papers 10
- Plasma miR-379 can predict treatment response to FOLFIRINOX and gemcitabine-nab-paclitaxel in advanced pancreatic cancer. Co-author DOI 10.1016/j.jlb.2024.100152↗
- Association of hypothyroidism with survival in pancreatic cancer: retrospective cohort study. Co-author DOI 10.1093/bjsopen/zrad119↗
- In-depth immune profiling of peripheral blood mononuclear cells in patients with pancreatic ductal adenocarcinoma reveals discriminative immune subpopulations. Co-author DOI 10.1111/cas.16147↗
- Prediction Model for Early-Stage Pancreatic Cancer Using Routinely Measured Blood Biomarkers. Co-author DOI 10.1001/jamanetworkopen.2023.31197↗
- Spatial immune composition of tumor microenvironment in patients with pancreatic cancer. Co-author DOI 10.1007/s00262-023-03573-6↗
- Diagnostic accuracy and added value of blood-based protein biomarkers for pancreatic cancer: A meta-analysis of aggregate and individual participant data. Co-author DOI 10.1016/j.eclinm.2022.101747↗
- hENT1 as a Predictive Biomarker in PDAC-Letter. Co-author DOI 10.1158/1078-0432.ccr-22-3827↗
- The Diagnostic Value of the CA19-9 and Bilirubin Ratio in Patients with Pancreatic Cancer, Distal Bile Duct Cancer and Benign Periampullary Diseases, a Novel A… Co-author DOI 10.3390/cancers14020344↗
- The Proteomic Landscape of Pancreatic Ductal Adenocarcinoma Liver Metastases Identifies Molecular Subtypes and Associations with Clinical Response-Letter. First author DOI 10.1158/1078-0432.ccr-21-0775↗
- Combined Expression of Plasma Thrombospondin-2 and CA19-9 for Diagnosis of Pancreatic Cancer and Distal Cholangiocarcinoma: A Proteome Approach. Co-author DOI 10.1634/theoncologist.2019-0680↗
Closest collaborators
The 25 strongest of 26 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Geert Kazemier M · 10 shared papers, 2020–2024 · strength 1.63
- Paper hENT1 as a Predictive Biomarker in PDAC-Letter. DOI 10.1158/1078-0432.ccr-22-3827↗
- Paper The Proteomic Landscape of Pancreatic Ductal Adenocarcinoma Liver Metastases Identifies Molecular Subtypes and Associat… DOI 10.1158/1078-0432.ccr-21-0775↗
- Paper In-depth immune profiling of peripheral blood mononuclear cells in patients with pancreatic ductal adenocarcinoma revea… DOI 10.1111/cas.16147↗
- Elisa Giovannetti · 9 shared papers, 2020–2024 · strength 1.46
- Paper hENT1 as a Predictive Biomarker in PDAC-Letter. DOI 10.1158/1078-0432.ccr-22-3827↗
- Paper The Proteomic Landscape of Pancreatic Ductal Adenocarcinoma Liver Metastases Identifies Molecular Subtypes and Associat… DOI 10.1158/1078-0432.ccr-21-0775↗
- Paper In-depth immune profiling of peripheral blood mononuclear cells in patients with pancreatic ductal adenocarcinoma revea… DOI 10.1111/cas.16147↗
- Tessa Y. S. Le Large · 8 shared papers, 2020–2024 · strength 1.30
- Paper hENT1 as a Predictive Biomarker in PDAC-Letter. DOI 10.1158/1078-0432.ccr-22-3827↗
- Paper The Proteomic Landscape of Pancreatic Ductal Adenocarcinoma Liver Metastases Identifies Molecular Subtypes and Associat… DOI 10.1158/1078-0432.ccr-21-0775↗
- Paper In-depth immune profiling of peripheral blood mononuclear cells in patients with pancreatic ductal adenocarcinoma revea… DOI 10.1111/cas.16147↗
- Laura L. Meijer · 7 shared papers, 2020–2024 · strength 1.10
- Paper hENT1 as a Predictive Biomarker in PDAC-Letter. DOI 10.1158/1078-0432.ccr-22-3827↗
- Paper In-depth immune profiling of peripheral blood mononuclear cells in patients with pancreatic ductal adenocarcinoma revea… DOI 10.1111/cas.16147↗
- Paper Plasma miR-379 can predict treatment response to FOLFIRINOX and gemcitabine-nab-paclitaxel in advanced pancreatic cance… DOI 10.1016/j.jlb.2024.100152↗
- Hanneke W.M. van Laarhoven · 6 shared papers, 2020–2024 · strength 0.92
- Paper hENT1 as a Predictive Biomarker in PDAC-Letter. DOI 10.1158/1078-0432.ccr-22-3827↗
- Paper Diagnostic accuracy and added value of blood-based protein biomarkers for pancreatic cancer: A meta-analysis of aggrega… DOI 10.1016/j.eclinm.2022.101747↗
- Paper Plasma miR-379 can predict treatment response to FOLFIRINOX and gemcitabine-nab-paclitaxel in advanced pancreatic cance… DOI 10.1016/j.jlb.2024.100152↗
- Jisce R. Puik · 4 shared papers, 2022–2024 · strength 0.65
- Paper hENT1 as a Predictive Biomarker in PDAC-Letter. DOI 10.1158/1078-0432.ccr-22-3827↗
- Paper Plasma miR-379 can predict treatment response to FOLFIRINOX and gemcitabine-nab-paclitaxel in advanced pancreatic cance… DOI 10.1016/j.jlb.2024.100152↗
- Paper Prediction Model for Early-Stage Pancreatic Cancer Using Routinely Measured Blood Biomarkers. DOI 10.1001/jamanetworkopen.2023.31197↗
- Marc G. Besselink · 3 shared papers, 2023–2024 · strength 0.50
- Paper Diagnostic accuracy and added value of blood-based protein biomarkers for pancreatic cancer: A meta-analysis of aggrega… DOI 10.1016/j.eclinm.2022.101747↗
- Paper Plasma miR-379 can predict treatment response to FOLFIRINOX and gemcitabine-nab-paclitaxel in advanced pancreatic cance… DOI 10.1016/j.jlb.2024.100152↗
- Paper Prediction Model for Early-Stage Pancreatic Cancer Using Routinely Measured Blood Biomarkers. DOI 10.1001/jamanetworkopen.2023.31197↗
- Eline S. Zwart · 3 shared papers, 2022–2024 · strength 0.49
- Paper In-depth immune profiling of peripheral blood mononuclear cells in patients with pancreatic ductal adenocarcinoma revea… DOI 10.1111/cas.16147↗
- Paper Spatial immune composition of tumor microenvironment in patients with pancreatic cancer. DOI 10.1007/s00262-023-03573-6↗
- Paper The Diagnostic Value of the CA19-9 and Bilirubin Ratio in Patients with Pancreatic Cancer, Distal Bile Duct Cancer and … DOI 10.3390/cancers14020344↗
- Annalisa Comandatore · 3 shared papers, 2023–2024 · strength 0.49
- Paper Plasma miR-379 can predict treatment response to FOLFIRINOX and gemcitabine-nab-paclitaxel in advanced pancreatic cance… DOI 10.1016/j.jlb.2024.100152↗
- Paper Association of hypothyroidism with survival in pancreatic cancer: retrospective cohort study. DOI 10.1093/bjsopen/zrad119↗
- Paper Prediction Model for Early-Stage Pancreatic Cancer Using Routinely Measured Blood Biomarkers. DOI 10.1001/jamanetworkopen.2023.31197↗
- Ingrid Garajová · 3 shared papers, 2023–2024 · strength 0.49
- Paper Plasma miR-379 can predict treatment response to FOLFIRINOX and gemcitabine-nab-paclitaxel in advanced pancreatic cance… DOI 10.1016/j.jlb.2024.100152↗
- Paper Association of hypothyroidism with survival in pancreatic cancer: retrospective cohort study. DOI 10.1093/bjsopen/zrad119↗
- Paper Prediction Model for Early-Stage Pancreatic Cancer Using Routinely Measured Blood Biomarkers. DOI 10.1001/jamanetworkopen.2023.31197↗
- Luca Morelli · 3 shared papers, 2023–2024 · strength 0.49
- Paper Plasma miR-379 can predict treatment response to FOLFIRINOX and gemcitabine-nab-paclitaxel in advanced pancreatic cance… DOI 10.1016/j.jlb.2024.100152↗
- Paper Association of hypothyroidism with survival in pancreatic cancer: retrospective cohort study. DOI 10.1093/bjsopen/zrad119↗
- Paper Prediction Model for Early-Stage Pancreatic Cancer Using Routinely Measured Blood Biomarkers. DOI 10.1001/jamanetworkopen.2023.31197↗
- Yvette van Kooyk · 2 shared papers, 2023–2024 · strength 0.35
- Ernesto Rodríguez · 2 shared papers, 2023–2024 · strength 0.35
- Adam Enver Frampton · 2 shared papers, 2023–2024 · strength 0.32
- Freek D. Daams · 2 shared papers, 2020–2022 · strength 0.23
- Paper The Diagnostic Value of the CA19-9 and Bilirubin Ratio in Patients with Pancreatic Cancer, Distal Bile Duct Cancer and … DOI 10.3390/cancers14020344↗
- Paper Combined Expression of Plasma Thrombospondin-2 and CA19-9 for Diagnosis of Pancreatic Cancer and Distal Cholangiocarcin… DOI 10.1634/theoncologist.2019-0680↗
- Babs M. Zonderhuis · 2 shared papers, 2020–2022 · strength 0.23
- Paper The Diagnostic Value of the CA19-9 and Bilirubin Ratio in Patients with Pancreatic Cancer, Distal Bile Duct Cancer and … DOI 10.3390/cancers14020344↗
- Paper Combined Expression of Plasma Thrombospondin-2 and CA19-9 for Diagnosis of Pancreatic Cancer and Distal Cholangiocarcin… DOI 10.1634/theoncologist.2019-0680↗
- Andrea Mambrini · 1 shared paper, 2024 · strength 0.17
- Johanna W. Wilmink · 1 shared paper, 2024 · strength 0.17
- Rutger‐Jan Swijnenburg · 1 shared paper, 2024 · strength 0.17
- Andrea Spallanzani · 1 shared paper, 2024 · strength 0.16
- Francesco Leonardi · 1 shared paper, 2024 · strength 0.16
- Gregorio Di Franco · 1 shared paper, 2024 · strength 0.16
- Rita Balsano · 1 shared paper, 2024 · strength 0.16
- Manuel Gentiluomo · 1 shared paper, 2024 · strength 0.16
- Connie R. Jiménez · 1 shared paper, 2020 · strength 0.09
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.